Shaky Earnings May Not Tell The Whole Story For Jiujiang Defu Technology (SZSE:301511)

The recent earnings release from Jiujiang Defu Technology Co., Limited (SZSE:301511 ) was disappointing to investors. We think that they may have more to worry about than just soft profit numbers.

See our latest analysis for Jiujiang Defu Technology

earnings-and-revenue-history
SZSE:301511 Earnings and Revenue History April 25th 2024
Advertisement

Zooming In On Jiujiang Defu Technology's Earnings

In high finance, the key ratio used to measure how well a company converts reported profits into free cash flow (FCF) is the accrual ratio (from cashflow). In plain english, this ratio subtracts FCF from net profit, and divides that number by the company's average operating assets over that period. The ratio shows us how much a company's profit exceeds its FCF.

That means a negative accrual ratio is a good thing, because it shows that the company is bringing in more free cash flow than its profit would suggest. While it's not a problem to have a positive accrual ratio, indicating a certain level of non-cash profits, a high accrual ratio is arguably a bad thing, because it indicates paper profits are not matched by cash flow. Notably, there is some academic evidence that suggests that a high accrual ratio is a bad sign for near-term profits, generally speaking.

Jiujiang Defu Technology has an accrual ratio of 0.31 for the year to December 2023. We can therefore deduce that its free cash flow fell well short of covering its statutory profit, suggesting we might want to think twice before putting a lot of weight on the latter. In the last twelve months it actually had negative free cash flow, with an outflow of CN¥1.9b despite its profit of CN¥132.6m, mentioned above. Coming off the back of negative free cash flow last year, we imagine some shareholders might wonder if its cash burn of CN¥1.9b, this year, indicates high risk. However, that's not all there is to consider. The accrual ratio is reflecting the impact of unusual items on statutory profit, at least in part.

Note: we always recommend investors check balance sheet strength. Click here to be taken to our balance sheet analysis of Jiujiang Defu Technology.

How Do Unusual Items Influence Profit?

The fact that the company had unusual items boosting profit by CN¥149m, in the last year, probably goes some way to explain why its accrual ratio was so weak. We can't deny that higher profits generally leave us optimistic, but we'd prefer it if the profit were to be sustainable. We ran the numbers on most publicly listed companies worldwide, and it's very common for unusual items to be once-off in nature. And that's as you'd expect, given these boosts are described as 'unusual'. Jiujiang Defu Technology had a rather significant contribution from unusual items relative to its profit to December 2023. All else being equal, this would likely have the effect of making the statutory profit a poor guide to underlying earnings power.

Our Take On Jiujiang Defu Technology's Profit Performance

Summing up, Jiujiang Defu Technology received a nice boost to profit from unusual items, but could not match its paper profit with free cash flow. For the reasons mentioned above, we think that a perfunctory glance at Jiujiang Defu Technology's statutory profits might make it look better than it really is on an underlying level. In light of this, if you'd like to do more analysis on the company, it's vital to be informed of the risks involved. To that end, you should learn about the 4 warning signs we've spotted with Jiujiang Defu Technology (including 3 which are significant).

Our examination of Jiujiang Defu Technology has focussed on certain factors that can make its earnings look better than they are. And, on that basis, we are somewhat skeptical. But there is always more to discover if you are capable of focussing your mind on minutiae. For example, many people consider a high return on equity as an indication of favorable business economics, while others like to 'follow the money' and search out stocks that insiders are buying. While it might take a little research on your behalf, you may find this free collection of companies boasting high return on equity, or this list of stocks that insiders are buying to be useful.

New: Manage All Your Stock Portfolios in One Place

We've created the ultimate portfolio companion for stock investors, and it's free.

• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks

Try a Demo Portfolio for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

About SZSE:301511

Jiujiang Defu Technology

Engages in the research, development, production, and sale of electrolytic copper foils in China.

Slight risk and slightly overvalued.

Advertisement

Weekly Picks

TA
Talos
TSLA logo
Talos on Tesla ·

The "Physical AI" Monopoly – A New Industrial Revolution

Fair Value:US$665.3636.1% undervalued
18 users have followed this narrative
7 users have commented on this narrative
12 users have liked this narrative
MA
CSG logo
Marek_Trnka on CSG ·

Czechoslovak Group - is it really so hot?

Fair Value:€5541.6% undervalued
25 users have followed this narrative
1 users have commented on this narrative
12 users have liked this narrative
AL
alex30free
SECARE logo
alex30free on Swedencare ·

The Compound Effect: From Acquisition to Integration

Fair Value:SEK 46.2847.8% undervalued
5 users have followed this narrative
0 users have commented on this narrative
1 users have liked this narrative

Updated Narratives

AN
AnimalDoctorKwon
NOTV logo
AnimalDoctorKwon on Inotiv ·

Inotiv NAMs Test Center

Fair Value:US$1.272.3% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
PI
PittTheYounger
DAL logo
PittTheYounger on Delta Air Lines ·

Delta loses shine after warning of falling travel demand, but still industry leader

Fair Value:US$63.2117.8% overvalued
18 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
RA
Ravedigga
ALRT logo
Ravedigga on Defence Holdings ·

Project Ixian Accelerated Rollout will Drive Valuation Expansion to £0.0150.

Fair Value:UK£0.01516.7% undervalued
4 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Popular Narratives

OO
NEO logo
OOO97 on Neo Performance Materials ·

Undervalued Key Player in Magnets/Rare Earth

Fair Value:CA$25.3317.8% undervalued
78 users have followed this narrative
0 users have commented on this narrative
20 users have liked this narrative
DA
davidlsander
UBI logo
davidlsander on Ubisoft Entertainment ·

Is Ubisoft the Market’s Biggest Pricing Error? Why Forensic Value Points to €33 Per Share

Fair Value:€33.886.2% undervalued
58 users have followed this narrative
5 users have commented on this narrative
25 users have liked this narrative
BL
BlackJesus
ADBE logo
BlackJesus on Adobe ·

The Strategic Revaluation of Adobe: A Critical Analysis of Market Sentiment

Fair Value:US$46042.5% undervalued
34 users have followed this narrative
2 users have commented on this narrative
22 users have liked this narrative
Advertisement